Related Articles by Review for PMID: 22969858

Year	Number of Results
2000	2
2001	4
2005	2
2006	1
2007	2
2008	2
2009	1
2011	1
2012	1
2014	2
2016	1
2017	1
2018	1
2022	1
2024	0

1

Quality of life in advanced non-small cell lung cancer patients receiving palliative chemotherapy: A meta-analysis of randomized controlled trials.

Matsuda A, Yamaoka K, Tango T. Matsuda A, et al. Exp Ther Med. 2012 Jan;3(1):134-140. doi: 10.3892/etm.2011.368. Epub 2011 Oct 18. Exp Ther Med. 2012. PMID: 22969858 Free PMC article.

2

A systematic overview of chemotherapy effects in non-small cell lung cancer.

Sörenson S, Glimelius B, Nygren P; SBU-group. Swedish Council of Technology Assessment in Health Care. Sörenson S, et al. Acta Oncol. 2001;40(2-3):327-39. doi: 10.1080/02841860151116402. Acta Oncol. 2001. PMID: 11441939 Review.

3

A systematic review of quality of life associated with standard chemotherapy regimens for advanced non-small cell lung cancer.

Tanvetyanon T, Soares HP, Djulbegovic B, Jacobsen PB, Bepler G. Tanvetyanon T, et al. J Thorac Oncol. 2007 Dec;2(12):1091-7. doi: 10.1097/JTO.0b013e31815cff64. J Thorac Oncol. 2007. PMID: 18090580 Free article. Review.

4

Best supportive care in non-small cell lung cancer: is there a role for radiotherapy and chemotherapy?

Numico G, Russi E, Merlano M. Numico G, et al. Lung Cancer. 2001 Jun;32(3):213-26. doi: 10.1016/s0169-5002(00)00222-1. Lung Cancer. 2001. PMID: 11390003 Review.

5

Paclitaxel: a pharmacoeconomic review of its use in non-small cell lung cancer.

Plosker GL, Hurst M. Plosker GL, et al. Pharmacoeconomics. 2001;19(11):1111-34. doi: 10.2165/00019053-200119110-00005. Pharmacoeconomics. 2001. PMID: 11735678 Review.

6

A systematic overview of chemotherapy effects in ovarian cancer.

Högberg T, Glimelius B, Nygren P; SBU-group. Swedish Council of Technology Assessment in Health Care. Högberg T, et al. Acta Oncol. 2001;40(2-3):340-60. doi: 10.1080/02841860151116420. Acta Oncol. 2001. PMID: 11441940 Review.

7

Taxanes as first-line therapy for advanced non-small cell lung cancer: a systematic review and practice guideline.

Chu Q, Vincent M, Logan D, Mackay JA, Evans WK; Lung Cancer Disease Site Group of Cancer Care Ontario's Program in Evidence-based Care. Chu Q, et al. Lung Cancer. 2005 Dec;50(3):355-74. doi: 10.1016/j.lungcan.2005.06.010. Epub 2005 Aug 31. Lung Cancer. 2005. PMID: 16139391 Review.

8

Excision repair cross-complementation group 1 (ERCC1) in platinum-based treatment of non-small cell lung cancer with special emphasis on carboplatin: a review of current literature.

Vilmar A, Sørensen JB. Vilmar A, et al. Lung Cancer. 2009 May;64(2):131-9. doi: 10.1016/j.lungcan.2008.08.006. Epub 2008 Sep 19. Lung Cancer. 2009. PMID: 18804893 Review.

9

Efficacy and side effects of cisplatin- and carboplatin-based doublet chemotherapeutic regimens versus non-platinum-based doublet chemotherapeutic regimens as first line treatment of metastatic non-small cell lung carcinoma: a systematic review of randomized controlled trials.

Rajeswaran A, Trojan A, Burnand B, Giannelli M. Rajeswaran A, et al. Lung Cancer. 2008 Jan;59(1):1-11. doi: 10.1016/j.lungcan.2007.07.012. Epub 2007 Aug 27. Lung Cancer. 2008. PMID: 17720276 Review.

10

Effect of specialist palliative care services on quality of life in adults with advanced incurable illness in hospital, hospice, or community settings: systematic review and meta-analysis.

Gaertner J, Siemens W, Meerpohl JJ, Antes G, Meffert C, Xander C, Stock S, Mueller D, Schwarzer G, Becker G. Gaertner J, et al. BMJ. 2017 Jul 4;357:j2925. doi: 10.1136/bmj.j2925. BMJ. 2017. PMID: 28676557 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

19 results

Results by year